Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genentech › Deepak Sampath
DS

Deepak Sampath — 17 Patents

Genentech: 17 patents #143 of 2,392Top 6%
AVAbb Vie: 4 patents #384 of 1,257Top 35%
Hoffmann-La Roche: 4 patents #813 of 3,238Top 30%
FAF. Hoffmann-La Roche Ag: 3 patents #68 of 425Top 20%
South San Francisco, CA: #123 of 1,066 inventorsTop 15%
California: #35,467 of 386,348 inventorsTop 10%
Overall (All Time): #263,971 of 4,157,543Top 7%
17 Patents All Time
Deepak Sampath has been granted 17 US patents while listed as an inventor at Genentech. The first was granted in 2012 and the most recent in February 2023. Deepak Sampath ranks #263,971 of 4,157,543 US inventors in our database (top 6.3%). Patent records list Deepak Sampath in South San Francisco, CA, US.

Issued Patents All Time

Showing 1–17 of 17 patents

Patent #TitleCo-InventorsDate
11590128 Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor Christian Klein, Wayne Fairbrother, Sari L. Heitner Enschede, Rod A. Humerickhouse, Andrew W. Roberts +1 more 2023-02-28
11413282 Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor Christian Klein, Wayne Fairbrother 2022-08-16
11110087 Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor Christian Klein, Wayne Fairbrother, Sari L. Heitner Enschede, Rod A. Humerickhouse, Andrew W. Roberts +1 more 2021-09-07
10993942 Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor Christian Klein, Wayne Fairbrother, Sari L. Heitner Enschede, Rod A. Humerickhouse, Andrew W. Roberts +1 more 2021-05-04
10959993 Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment of cancer Mark Merchant, Marina Konopleva, Lina Han 2021-03-30
10898570 Combination therapy with an anti-HER2 antibody-drug conjugate and a Bcl-2 inhibitor Gail Lewis Phillips, Ingrid Wertz 2021-01-26
10092567 Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use Kui Lin, Michelle Nannini, Elizabeth Punnoose, Jeffrey Wallin, Premal Patel 2018-10-09
9855270 Methods and compositions for modulating estrogen receptor mutants Jeffrey J. Hager, James D. Joseph, Jing Qian, Nicholas D. Smith, Edna Chow Maneval +2 more 2018-01-02
9717730 Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use Kui Lin, Michelle Nannini, Elizabeth Punnoose, Jeffrey Wallin, Premal Patel 2017-08-01
9682082 Combinations of AKT and MEK inhibitor compounds, and methods of use Brian Lee, Kui Lin, Michelle Nannini, Elizabeth Punnoose 2017-06-20
9610289 Combinations of AKT inhibitor compounds and erlotinib, and methods of use Michelle Nannini 2017-04-04
9539251 Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor Christian Klein, Wayne Fairbrother 2017-01-10
9346789 Combinations of AKT inhibitor compounds and abiraterone, and methods of use Michelle Nannini 2016-05-24
9150549 Combinations of AKT inhibitor compounds and erlotinib, and methods of use Michelle Nannini 2015-10-06
9107926 Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer Marcia Belvin, Lori Friedman, Jeffrey Wallin 2015-08-18
8604014 Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic agents, and methods of use Marcia Belvin, Lori Friedman, Klaus Hoeflich, Ulka Vijapurkar, Jeffrey Wallin +3 more 2013-12-10
8247397 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use Marcia Belvin, Lori Friedman, Klaus Hoeflich, Ulka Vijapurkar, Jeffrey Wallin +3 more 2012-08-21

Nearby-Ranked Inventors

Michael John Caelwaerts17
Umut Zalluhoglu17
Austino Longo17
Till Bredbeck17
Mircea Grigore17
Achim Klein17
Manesh Nadupparambil Sekharan17
Yoshiaki Nishikawa17
Evan Sparks17